Bendroflumethiazide
From Wikipedia, the free encyclopedia
|
Bendroflumethiazide
|
|
| Systematic (IUPAC) name | |
| 3-benzyl-5,5-dioxo-9- (trifluoromethyl)-5λ6- thia-2,4-diazabicyclo[4.4.0]deca-7, 9,11-triene-8-sulfonamide | |
| Identifiers | |
| CAS number | |
| ATC code | C03 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C15H14F3N3O4S2 |
| Mol. mass | 421.417 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 100% |
| Protein binding | 96% |
| Metabolism | extensive |
| Half life | 3-4 hours[1] |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
Risk neonatal thrombocytopenia in 3rd trimester[2] |
| Legal status | |
| Routes | oral |
Bendroflumethiazide INN (formerly BAN bendrofluazide), is a thiazide diuretic, used to treat hypertension.
[edit] Footnotes
- ^ in Ed. Sean C. Sweetman: Martindale: The complete drug reference, 33, Pharmaceutical Press.
- ^ BNF 45 March 2003
[edit] External links
|
||||||||||||||||||||

